New Zealand markets closed

Marker Therapeutics Inc (GX1.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
4.3200-0.0200 (-0.46%)
At close: 08:08PM CEST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
15,111
11,782
42,351
21,352
-
Total cash
15,111
11,782
42,351
21,352
-
Total current assets
17,127
16,619
45,982
24,411
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
-
23,077
24,893
21,795
978.174
Accumulated depreciation
-
-5,274
-2,740
-591
-105
Net property, plant and equipment
-
17,803
22,153
21,204
873.174
Other long-term assets
-
17,803
-
-
-
Total non-current assets
0
17,803
22,153
21,204
-
Total assets
17,127
34,422
68,135
45,615
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
961
1,101
5,144
2,935
-
Accrued liabilities
1,838
670
3,936
1,384
-
Deferred revenues
-
2,500
1,146
0
-
Other current liabilities
-1,330
5,261
-0.087
0.01
-
Total current liabilities
3,075
7,782
12,902
6,402
-
Non-current liabilities
Total non-current liabilities
0
7,039
11,248
11,868
-
Total liabilities
3,075
14,821
24,150
18,270
-
Stockholders' equity
Common stock
8.891
8.406
8.308
50.731
-
Retained earnings
-436,286
-428,049
-398,118
-356,239
-
Total stockholders' equity
14,053
19,601
43,986
27,345
-
Total liabilities and stockholders' equity
17,127
34,422
68,135
45,615
-